Scientists from India, US can widen research under special tech fund: Envoy

There are at least three ongoing collaborations of Indian and US companies and institutions to co-develop and produce a COVID-19 vaccine," he said

coronavirus testing
India has been working with the US private sector in vaccine development.
Press Trust of India Houston
2 min read Last Updated : Aug 11 2020 | 8:49 AM IST

Scientists and engineers from India and the US can widen their opportunities for research under the COVID-19 Virtual Networks that is being developed as part of the India-US Science and Technology Endowment Fund(IUSTEF), Indian Ambassador Taranjit Singh Sandhu has said.

Speaking at a webinar titled India-US Partnership, healthcare and medical research, Sandhu said scientists and engineers from India and the US have tremendous scope for bilateral cooperation in the area of healthcare and medical research during the current time of coronavirus pandemic.

"India and the US are actively engaged in healthcare and medical research during COVID-19 pandemic and there is a tremendous scope for bilateral cooperation in this area that needs to be tapped and build on the synergies that exist in this sector," Sandhu said.

"Since the initial days of the outbreak of COVID, our scientists and institutions have been actively engaged in exchange of information. COVID-19 Virtual Networks being developed under IUSTEF will allow Indian and the US scientists and engineers to carry our joint research activities virtually and leverage current infrastructure and funding mechanism," he added.

The aim of USISTEF is to support and foster joint applied R&D to generate public good through the commercialisation of technology developed through sustained partnerships between US and Indian researchers and entrepreneurs.

Sandhu highlighted the works being done by the India with the US private sector.

India has been working with the US private sector in vaccine development. There are at least three ongoing collaborations of Indian and US companies and institutions to co-develop and produce a COVID-19 vaccine," he said.

The interactive panel for the webinar comprised high ranking officials like Dr P D Vaghela, Secretary Department of Pharmaceuticals, India, Dr Peter Hotez, infectious disease specialist and a pediatrician at the Baylor College of Medicine in Houston and Susan Davenport, Sr VP, Economic Development, Greater Houston Partnership.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusLockdownCoronavirus TestsCoronavirus VaccineHealth Ministry

First Published: Aug 11 2020 | 8:39 AM IST

Next Story